Published in Genetics and Environmental Business Week, August 13th, 2009
ATRI will realize the Angelman Syndrome Foundation's "scientific roadmap" that directs its aggressive funding of Angelman Syndrome (AS) research. AS occurs in one in every 15,000 live births and...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Genetics and Environmental Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.